Therapeutic supramolecular tubustecan hydrogel combined with checkpoint inhibitor elicits immunity to combat cancer
Author:
Funder
Johns Hopkins University
Publisher
Elsevier BV
Subject
Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering
Reference58 articles.
1. Nivolumab for recurrent squamous-cell carcinoma of the head and neck;Ferris;N. Engl. J. Med.,2016
2. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial;Kaufman;Lancet Oncol.,2016
3. The future of immune checkpoint cancer therapy after PD-1 and CTLA-4;Hahn;Immunotherapy,2017
4. The future of immune checkpoint therapy;Sharma;Science,2015
5. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors;Curran;Proc. Natl. Acad. Sci. U. S. A.,2010
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell‐Based Cancer Immunotherapy;Advanced Materials;2023-12
2. Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy;Acta Pharmaceutica Sinica B;2023-12
3. Ferritin‐Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy;Advanced Science;2023-11-29
4. Light-Assisted “Nano-Neutrophils” with High Drug Loading for Targeted Cancer Therapy;International Journal of Nanomedicine;2023-11
5. Utilizing the Hofmeister Effect to Induce Hydrogelation of Nonionic Supramolecular Polymers into a Therapeutic Depot;Angewandte Chemie International Edition;2023-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3